Advertisement

Topics

Latest "Evogene EVGN Financial Strategic SWOT Analysis Review Updated" News Stories

19:03 EDT 19th March 2019 | BioPortfolio

Here are the most relevant search results for "Evogene EVGN Financial Strategic SWOT Analysis Review Updated" found in our extensive news archives from over 250 global news sources.

More Information about Evogene EVGN Financial Strategic SWOT Analysis Review Updated on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Evogene EVGN Financial Strategic SWOT Analysis Review Updated for you to read. Along with our medical data and news we also list Evogene EVGN Financial Strategic SWOT Analysis Review Updated Clinical Trials, which are updated daily. BioPortfolio also has a large database of Evogene EVGN Financial Strategic SWOT Analysis Review Updated Companies for you to search.

Showing "Evogene EVGN Financial Strategic SWOT Analysis Review Updated" News Articles 1–25 of 31,000+

Tuesday 19th March 2019

Aurinia Reports Fourth Quarter and Full Year 2018 Financial Results and Operational Highlights

Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH / TSX: AUP) (“Aurinia” or the “Company”) today reported its financial results for the fourth quarter and year ended December 31, 2018. Amounts, unless specified otherwise, are expressed in U.S. dollars. 2018 and Recent Highlights Notice of Allowance from the United States Patent ...


SOTIO’s DCVAC/OvCa Significantly Improves Survival in Patients with Recurrent Ovarian Cancer

DCVAC/OvCa decreased the risk of death in second line treatment of ovarian cancer by 62% Overall survival (OS) increased significantly by 13.4 months. Median Progression Free Survival (mPFS) increased by 1.8 months. SOTIO plans to initiate a global Phase III study with DCVAC/OvCa SOTIO, a biotechno...

FRESH Study Results Show Passive Leg Raise May Predict Cardiac Dysfunction in Septic Shock Patients

Data analysis leveraging Cheetah Medical technology presented at International Symposium on Intensive Care and Emergency Medicine (ISICEM) Cheetah Medical, a Massachusetts-based leader in non-invasive fluid management devices, today announced new results of a sepsis data analysis leveraging Cheetah Medical technology. The findings were presented at the...


Mississippi Health System Expands Partnership with CPSI

Jasper General Hospital Selects EHR and Revenue Cycle Offerings to Reach All Points of Care Evident LLC, a wholly owned subsidiary of CPSI (NASDAQ: CPSI) and a leading provider of electronic health record (EHR) systems and services, announced today that Jasper General Hospital has selected the cloud-hosted Thrive EHR solution for their hospital and cli...

Concord Medical Announces New Appointments to Management Team

BEIJING, March 19, 2019 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a leading specialty hospital management solutions provider and an operator of the largest network of radiotherapy and diagnostic imaging centers in China, today announced three new appointments to the management team. Concord Medical's board of di...

Regenerated Catalyst Global Market Research and Forecast, 20152025 [Report Updated: 01011970] Prices from USD $2200

SummaryThe Regenerated Catalyst report provides an independent information about the Regenerated Catalyst industry supported by extensive research on factors such as industry segmentssize trends, inhibitors, dynamics, drivers, opportunities challenges, environment policy, cost overview, porter's five force analysis, and key companies profiles including business overview and recent development...

Press Ganey Launches Blueprint for Transformational Change, “Translating Strategy Into Action”

White Paper Presents Approach to Achieving Enterprise-Wide Improvement Press Ganey today released its 2019 Strategic Insights white paper, Accelerating Transformation: Translating Strategy Into Action

New GEN eBook featuring a collection of 8 educational articles that review technological advantages of a high-throughput flow cytometry platform built for screening. Download your free copy! http://ow.ly/Wv0930o2QuB pic.twitter.com/YJbobkSn56

New GEN eBook featuring a collection of 8 educational articles that review technological advantages of a high-throughput flow cytometry platform built for screening. Download your free copy! http://ow.ly/Wv0930o2QuB  pic.twitter.com/YJbobkSn56

San Francisco officials look to ban sale of e-cigarettes

San Francisco officials on Tuesday proposed legislation that would ban the sale of e-cigarettes from companies such as Juul until a review by the U.S. Food and Drug Administration, as part of the city's efforts to tackle underage vaping.

VALBIOTIS Strengthens Its Supervisory Board with the Appointment of Agnès TIXIER

• 25 years of experience leading finance departments for international companies • Expertise in strategic and financial management for listed companies, particularly with the establishment of European public financing related to innovation Regulatory News: VALBIOTIS (FR0013254851 – ALVAL / PEA/SME eligible), a French Rese...

Sartorius introduces Cubis II modular laboratory balances

Fully customisable enabling thousands of configurations optimised for the user’s workflow and easy, seamless integration with existing lab software and LIMS... The post Sartorius introduces Cubis II modular laboratory balances appeared first on

FEI Launches New Website to Recognize 40 Years of Excellence

Redesigned site prioritizes user friendliness and highlights array of service offerings MILWAUKEE (PRWEB) March 19, 2019 FEI Behavioral Health, a social enterprise and leader in workforce resilience from EAP and organizational development to workplace violence prevention and crisis management, is celebrating 40 years of providing the best in resilience services. One of the oldest and most success...

Acting FDA Commissioner named

As Dr Scott Gottlieb steps down from his role next month, Dr Ned Sharpless has been announced as his short-term replacement... The post Acting FDA Commissioner named appeared first on European Pharmaceutical Review.

DeA Capital (DEA) - Platform developments and AUM growth

Edison Investment Research - Financials - DeA Capital: DeA Capital performed well in FY18 despite turbulent financial markets, developing its alternative asset management platform and growing AUM. Minority interests have been eliminated and net asset value grew. Strong cash flow continues, driven by net distributions from maturing fund investments, sufficient to fund reinvestment and strong distri...

Cerebral palsy in adults: summary of NICE guidance

What you need to knowOffer an annual review by a healthcare professional with expertise in neurodisabilities (who might be an advanced nurse practitioner, rehabilitation physician, physiotherapist,...

FDA Places Partial Clinical Hold on AbbVie’s Trials Evaluating Venetoclax in Multiple Myeloma

NORTH CHICAGO, Ill., March 19, 2019 /PRNewswire/ — AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, today announced the U.S. Food and Drug Administration (FDA) has placed a partial clinical hold on all clinical trials evaluating venetoclax (VENCLEXTA®/VENCLYXTO®) for the investigational treatment of multiple myeloma. The partial clinical hold follows a revi...

Puma Biotechnology Presents Interim Results from the Phase 2 Trial Evaluating Neratinib for HER2 Mutant, Metastatic Cervical Cancer

LOS ANGELES–(BUSINESS WIRE)–Puma Biotechnology, Inc. (Nasdaq: PBYI), a biopharmaceutical company, announced today that updated results from the cervical cancer cohort of SUMMIT, an ongoing Phase II basket trial examining the efficacy of neratinib in HER2-mutated cancers, were reported at the Society of Gynecologic Oncology (SGO) 2019 Annual Meeting in Honolulu, Hawaii. “Neratinib in ...

Camstent announces positive initial results for bacteria-phobic catheter

The study involved 10 Camstent coated catheters and 12 uncoated silicone catheters, which showed clear reduction in biofilm formation and biomineralisation on the Camstent polymer coated catheters compared The post Camstent announces positive initial results for bacteria-phobic catheter appeared first on Compelo Medical Devices - Latest industry news and analysis.

New ECG method uses signals from ear and hand to check heart rhythm

The ECG method, which does not require two hands could be used by drivers, athletes, and the military,  was revealed at EHRA 2019, the annual congress of the The post New ECG method uses signals from ear and hand to check heart rhythm appeared first on Compelo Medical Devices - Latest industry news and analysis.

Theranica raises $35m to bring advanced migraine device to US

All existing investors of the company – Lightspeed Venture Partners, LionBird, Corundum Open Innovation and Takoa – participated in the round. Nerivio Migra, the company’s novel remote neuromodulation The post Theranica raises $35m to bring advanced migraine device to US appeared first on Compelo Medical Devices - Latest industry news and analysis.

Prevencio announces two validation studies confirming high accuracy of HART AI-driven tests

Researchers believe these important findings, presented March 17 at the 2019 American College of Cardiology (ACC) Scientific Sessions in New Orleans, demonstrate the robustness and accuracy of these The post Prevencio announces two validation studies confirming high accuracy of HART AI-driven tests appeared first on Compelo Medical Devices - Latest industry news and analysis.

Synaptive Medical Appoints Sandra Clarke, CPA, CMA as Chief Financial Officer

Synaptive Medical, a global pioneer in automated surgical planning and robotics, today announced the appointment of Sandra Clarke, CPA, CMA as Chief Financial Officer. “Ms. Clarke is an incredible addition to our team,” said Peter Wehrly, CEO of Synaptive. “With her accomplished background and experience working for companies at critical inf...

New Research Highlights National Need for Recreational Activities to Support Children Facing Life-Threatening Illnesses

Growing national non-profit A Kid Again partners with Nationwide Children’s Hospital to gain valuable insights on children facing life-threatening illnesses COLUMBUS, Ohio (PRWEB) March 19, 2019 A Kid Again, a national non-profit organization that provides year-round recreational adventures to children and families dealing with life-threatening illnesses, announced today the results of a partne...

Global Specialty Injectable Generics Market to Surpass US$ 75.7 Billion by 2026 – Coherent Market Insights

According to Coherent Market Insights, the global specialty injectable generics market was valued at US$ 31,300 million in 2017, and is projected to exhibit a CAGR of 10.4% over the forecast period (2018 – 2026). Key Trends and Analysis of the Specialty Injectable Generics Market: Increasing prevalence of chronic diseases such as cancer...

Avricore Health Inc. Advisory Board Welcomes Mark Zhou

Avricore Health Inc. (TSXV:AVCR) (“Avricore Health”) is very pleased to announce that Mark Zhou will join the company’s Advisory Board and support  strategic operations and government affairs. The post Avricore Health Inc. Advisory Board Welcomes Mark Zhou appeared first on Investing News Network.


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks